Labuda Mitrović

Prognostic Value of CA125 Kinetics and Half-Life in Advanced Ovarian Cancer

Slobodanka Čolaković, Vesna Lukić, Labuda Mitrović et al. · The International Journal of Biological Markers · 2000 · 65 citations · Full text

Surgical Oncology, Cancer Management, Pathology +19

Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study

S. Jelić, Labuda Mitrović, Davorin Radosavljević et al. · Lung Cancer · 2001 · 43 citations

Mitomycin C, Medicine, Pathology +9

Daily oral etoposide in metastatic breast cancer

Zora Nešković‐Konstantinović, Snežana Bošnjak, Siniša Radulović et al. · Anti-Cancer Drugs · 1996 · 27 citations

Patient Statement of Satisfaction With Antiemetic Treatment Is Related to Quality of Life

Snežana Bošnjak, Sinia Radulovi ́c, Zora Nešković‐Konstantinović et al. · American Journal of Clinical Oncology · 2000 · 18 citations

Quality Of Life, Patient Statement, Cancer Management +16

Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.

Zora Nešković‐Konstantinović, Dragica Nikolić‐Vukosavljević, Mirjana Branković-Magić et al. · PubMed · 1999 · 17 citations

Tumor Biology, Breast Oncology, Early Stages +9